Literature DB >> 1328104

Germ cell testicular tumours with lung metastases: chemotherapy and surgical treatment.

S Cărsky1, D Ondrus, M Schnorrer, M Májek.   

Abstract

Eighty patients with stage IV testicular germ cell tumours with lung metastases were treated with PVB chemotherapy and subsequent surgery in cases of residual disease. Out of 80 patients 28 (35%) achieved complete response following chemotherapy alone. Thirty-six patients (45%) with partial response underwent surgery: 17 had lymphadenectomy because of residual mass in the retroperitoneum, 15 had pulmonary surgery alone and 4 had both operations. Of these 36 patients 27 achieved complete response following cytostatic and surgical treatment. Sixteen patients died following PVB chemotherapy, 10 of them due to progression of disease, and there were six (7.5%) drug-related deaths. The authors refer to the importance of surgical treatment of residual metastatic mass in the lungs following PVB chemotherapy. Germ cell tumours of the testis are the most curable solid neoplasms treated by the oncologist. Advances in their management are due to the introduction of cisplatin-based combination chemotherapy and surgical removal of the residual mass [8]. Progress in chemotherapy of testicular tumours has changed the attitude towards thoracotomy and surgical removal of lung metastases. The aim of this study is to evaluate combined cytostatic and surgical treatment of disseminated testicular tumours with emphasis on surgical removal of residual lung metastases following chemotherapy.

Entities:  

Mesh:

Year:  1992        PMID: 1328104     DOI: 10.1007/bf02549540

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

1.  The surgical management of multiple lung metastases.

Authors:  H Takita; C Merrin; M S Didolkar; H O Douglass; F Edgerton
Journal:  Ann Thorac Surg       Date:  1977-10       Impact factor: 4.330

2.  Indications for surgery for intrathoracic metastases in testicular carcinoma.

Authors:  N Martini; P M McCormack; M S Bains
Journal:  Semin Oncol       Date:  1979-03       Impact factor: 4.929

3.  The changing role of surgery for pulmonary metastases.

Authors:  P M McCormack; N Martini
Journal:  Ann Thorac Surg       Date:  1979-08       Impact factor: 4.330

4.  Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cis-platinum-based chemotherapy.

Authors:  S D Fosså; O Klepp; S Ous; H Lien; J T Stenwig; V Abeler; G Eliassen; H Høst
Journal:  Scand J Urol Nephrol       Date:  1984

5.  Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction.

Authors:  L H Einhorn; S D Williams; I Mandelbaum; J P Donohue
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

6.  Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy.

Authors:  W A Gelderman; H Schraffordt Koops; D T Sleijfer; J W Oosterhuis; J N Van der Heide; N H Mulder; J Marrink; H W De Bruyn; J Oldhoff
Journal:  J Surg Oncol       Date:  1988-08       Impact factor: 3.454

7.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

8.  Results of combined chemo-surgical therapy for pulmonary metastases from testicular carcinoma.

Authors:  M S Bains; P M McCormack; E Cvitkovic; R B Golbey; N Martini
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

9.  Thoracotomy as a staging procedure after chemotherapy in the treatment of Stage III nonseminomatous carcinoma of the testis.

Authors:  K Prenger; L Eysman; J N van der Heide; J Oldhoff; D T Sleijfer; H S Koops; J W Oosterhuis
Journal:  Ann Thorac Surg       Date:  1984-11       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.